相关实验视频

Updated: Jul 16, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

性乳腺癌的遗传分析:与临床结果的相关性

Kuikui Jiang¹, Danyang Zhou², Fei Xu¹

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.

|September 15, 2023

概括

基因组分析显示,PIK3CA H1047R突变和HER2阳性是形转移性乳腺癌的关键预后指标,改善了患者分层和疾病行为的理解.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
癌症生物学癌症生物学

背景情况:

研究小转移性乳腺癌的基因组景观.
了解遗传变化与临床结果之间的联系.

研究的目的:

为了确定与形转移性乳腺癌的临床结果相关的基因组特征.
探索预后标记,以改善患者分层.

主要方法:

形转移性和多转移性乳腺癌患者的回顾性审查 (2001年1月至2019年8月).
收集临床病理学数据和基因组改变信息.
形复发 (oligo-R) 的定义是进展在<5个部位.

主要成果:

皮克3CA,TP53和ERBB2是常见的变化.
PIK3CA H1047R突变与形转移和更好的预后相关 (形-R > 31.04 个月).
HER2阳性与形转移患者的良好结果相关.

结论:

皮克3CA H1047R和HER2状态在形和多转移性乳腺癌中具有预后价值.
改善了乳腺癌患者的预后分层. 形转移性乳腺癌患者.
对原转移性乳腺癌的生物行为的新见解.

关键词:

乳腺癌是什么? 乳腺癌是什么基因分析基因分析原转移性疾病的发生.奥利戈的复发情况.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...